Dataset from A Phase 1, Open-label, Multicenter Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of TAK-385 Alone in Hormone Treatment- naïve Japanese Patients With Non-metastatic Prostate Cancer
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009884
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the tolerability and safety of TAK-385 in hormone
treatment-naïve participants with non-metastatic prostate cancer.
创建时间：
2025-02-10
